RGNX Operating Cash Flow (Statement)
Regenxbio Inc · Operating Cash Flow (Statement)
RGNX Operating Cash Flow (Statement)
Latest reported-$246.67Mperiod ending
RGNX Cash from Operations (-$3.01M → -$246.67M)
Annual operating cash flow (statement)
High-resolution chart · PNG
RGNX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -123,963,000 | |
| -173,125,000 | |
| -218,407,000 | |
| -207,488,000 | |
| 218,875,000 | |
| -54,061,000 | |
| -107,705,000 | |
| 104,648,000 | |
| -57,992,000 | |
| -48,558,000 | |
| -22,515,000 | |
| -2,399,000 | |
| -3,012,000 |